Heidelberg Pharma

Heidelberg Pharma AG

This biopharmaceutical company develops antibody-drug conjugates for oncology patients using proprietary toxin technology to target and eliminate cancer cells.

Alphina Therapeutics

This biotechnology company develops antibody-drug conjugates with novel payloads to treat solid tumours for healthcare providers and cancer patients.

Araris Biotech

This company develops antibody-drug conjugate linker technology and targeted cancer therapies for pharmaceutical partners and patients.

Bead Biopharma

This company develops chemical platform technologies to improve the stability and performance of antibody-drug conjugates for pharmaceutical developers and cancer researchers.

Hexagon Bio

This biopharmaceutical company develops novel cytotoxic payloads for antibody-drug conjugates to treat cancer and infectious diseases for pharmaceutical and healthcare organisations.

SynAffix

This company licenses a technology platform for antibody-drug conjugate development to pharmaceutical and biotechnology firms to enable targeted cancer treatments.

Adcytherix

This biopharmaceutical company develops novel antibody-drug conjugates to treat various forms of cancer for patients with high unmet clinical needs.

Mablink Bioscience

This biotechnology firm develops antibody-drug conjugates for pharmaceutical companies to treat cancer using a proprietary hydrophilic linker platform.